{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:37:24Z","timestamp":1790973444274,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T00:00:00Z","timestamp":1287532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background &amp; aims: <\/jats:bold> The use of low\u2010molecular\u2010weight heparins (LMWH) in patients with advanced liver diseases is frequently avoided because of the enhanced risk of bleeding complications. However, many patients with impaired liver function are at a high risk of thrombosis or have an indication for therapeutic anticoagulation. Therefore, the aim of this study was to evaluate the pharmacokinetics of LMWH in patients with cirrhosis.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Eighty\u2010four consecutive patients with cirrhosis and a clinical indication for prophylactic or therapeutic anticoagulation were included. The LMWH doses were chosen according to current guidelines. Antifactor Xa activity (anti\u2010Xa) was assessed on two consecutive days, 4\u2003h after drug administration. The severity of liver disease was quantified using Child\u2013Turcotte\u2013Pugh score, the MELD score and clinical features and was correlated with the anti\u2010Xa value and the occurrence of complications.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Antifactor Xa activity was negatively correlated with the severity of the liver disease, and a positive correlation was observed between antithrombin\u2010III (AT) levels and anti\u2010Xa value. AT itself was negatively correlated with the severity of liver disease. Seven patients had an episode of variceal bleeding. No patient died during the observation interval and no thromboembolic events occurred.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> Prophylactic use of LMWH in patients with cirrhosis appears to be safe. A decreased anti\u2010Xa value in cirrhotic patients and a negative correlation with liver function challenge the unconditional use of anti\u2010Xa assays in LMWH monitoring in cirrhotic patients and reveals a potential limitation of anti\u2010Xa analysis in these patients. Low levels of AT, because of reduced hepatic synthesis, are the most likely cause of this phenomenon.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2010.02358.x","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T09:13:24Z","timestamp":1287566004000},"page":"75-82","source":"Crossref","is-referenced-by-count":115,"title":["Low\u2010molecular\u2010weight heparin in patients with advanced cirrhosis"],"prefix":"10.1111","volume":"31","author":[{"given":"Lars P.","family":"Bechmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Sichau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Wichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Gerken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Hilgard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909093411103"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000138928.83266.24"},{"key":"e_1_2_7_4_2","first-page":"101","article-title":"International Consensus Statement (guidelines according to scientific evidence)","volume":"25","author":"Prevention and treatment of venous thromboembolism.","year":"2006","journal-title":"Int Angiol"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-9560-4-8"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1309\/8E3U7RXEPXNP27R7"},{"key":"e_1_2_7_7_2","first-page":"188S","article-title":"Heparin and low\u2010molecular\u2010weight heparin","volume":"126","author":"Hirsh J","year":"2004","journal-title":"the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy"},{"key":"e_1_2_7_8_2","first-page":"673","article-title":"Meta\u2010analysis","volume":"144","author":"Lim W","year":"2006","journal-title":"low-molecular-weight heparin and bleeding in patients with severe renal insufficiency"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.048181"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2003.11.003"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-23205"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02772.x"},{"key":"e_1_2_7_13_2","first-page":"1554","article-title":"Acute pulmonary embolism as the first manifestation of hepatocellular carcinoma complicated with tumor thrombi in the inferior vena cava","volume":"52","author":"Lin HH","year":"2007","journal-title":"surgery or not?"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21354"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000171542"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-7-34"},{"key":"e_1_2_7_17_2","first-page":"691","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation","volume":"54","author":"Francoz C","year":"2005","journal-title":"usefulness of screening and anticoagulation"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000084726"},{"key":"e_1_2_7_19_2","first-page":"381S","article-title":"Prevention of venous thromboembolism","volume":"133","author":"Geerts WH","year":"2008","journal-title":"American college of chest physicians evidence-based clinical practice guidelines (8th Edition)"},{"key":"e_1_2_7_20_2","first-page":"1282","article-title":"Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension","volume":"45","author":"Nguyen GC","year":"2007","journal-title":"a national study"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.015"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/107602960601200208"},{"key":"e_1_2_7_23_2","first-page":"693","article-title":"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease","volume":"36","author":"Goodman SG","year":"2000","journal-title":"one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events"},{"key":"e_1_2_7_24_2","first-page":"552","article-title":"Primary prophylaxis of variceal bleeding in cirrhotics awaiting liver transplantation","volume":"53","author":"Gheorghe C","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.10.004"},{"key":"e_1_2_7_26_2","first-page":"817","article-title":"Dosing in heavy\u2010weight\/obese patients with the LMWH, tinzaparin","volume":"87","author":"Hainer JW","year":"2002","journal-title":"a pharmacodynamic study"},{"key":"e_1_2_7_27_2","first-page":"1257","article-title":"Body composition, muscle function, and energy expenditure in patients with liver cirrhosis","volume":"85","author":"Peng S","year":"2007","journal-title":"a comprehensive study"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199803000-00004"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(86)90368-3"},{"issue":"3","key":"e_1_2_7_30_2","first-page":"10S","article-title":"Serpin receptor 1","volume":"87","author":"Pizzo SV","year":"1989","journal-title":"a hepatic receptor that mediates the clearance of antithrombin III\u2013proteinase complexes"},{"key":"e_1_2_7_31_2","first-page":"669","article-title":"Monitoring of heparin therapy","volume":"46","author":"Holm HA","year":"1987","journal-title":"should heparin assays also reflect the patient's antithrombin concentration?"},{"key":"e_1_2_7_32_2","first-page":"347","article-title":"Monitoring Unfractionated Heparin (UFH) therapy","volume":"120","author":"Ignjatovic V","year":"2007","journal-title":"which Anti-Factor Xa assay is appropriate?"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.08.077"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0604471103"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2010.02358.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2010.02358.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:50:12Z","timestamp":1697277012000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2010.02358.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,20]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1478-3231.2010.02358.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02358.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,20]]}}}